Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A1 | P04798 | 1/20 | 0.54 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.54 |
| ▸ | HDAC8 | Q9BY41 | 2/20 | 0.39 |
| ▸ | CA12 | O43570 | 2/20 | 0.37 |
| ▸ | CA1 | P00915 | 2/20 | 0.37 |
| ▸ | CA2 | P00918 | 2/20 | 0.37 |
| ▸ | CA9 | Q16790 | 2/20 | 0.37 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.37 |
| ▸ | CA4 | P22748 | 1/20 | 0.37 |
| ▸ | TYMS | P04818 | 1/20 | 0.37 |
| ▸ | CDC7 | O00311 | 1/20 | 0.36 |
| ▸ | CDK2 | P24941 | 1/20 | 0.36 |
| ▸ | ASIC3 | Q9UHC3 | 1/20 | 0.33 |
| ▸ | HTR7 | P34969 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.32 |
| ▸ | MAP3K14 | Q99558 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29870412 | 1.00 | CYP1A1 (0.54) | CYP1A1CYP1B1HDAC8CA12CA1 | |
| SCHEMBL10481157 | 0.97 | CYP1A1 (0.52) | CYP1A1CYP1B1HDAC8CA12CA1 | |
| SCHEMBL29203830 | 0.94 | CYP1A1 (0.50) | CYP1A1CYP1B1HDAC8CA12CA1 | |
| SCHEMBL12986899 | 0.91 | CYP1A1 (0.52) | CYP1A1CYP1B1HDAC8CA12CA1 | |
| SCHEMBL29832259 | 0.91 | CYP1A1 (0.52) | CYP1A1CYP1B1HDAC8CA12CA1 | |
| SCHEMBL30375647 | 0.89 | CYP1A1 (0.58) | CYP1A1CYP1B1CA1CA2CA9 | |
| SCHEMBL29750775 | 0.89 | CYP1A1 (0.58) | CYP1A1CYP1B1CA1CA2CA9 | |
| SCHEMBL825806 | 0.89 | CYP1A1 (0.58) | CYP1A1CYP1B1CA1CA2CA9 | |
| SCHEMBL11126903 | 0.87 | CYP1A1 (0.56) | CYP1A1CYP1B1CA12CA1CA2 | |
| SCHEMBL5778680 | 0.87 | IMPDH2 (0.45) | CYP1A1CYP1B1CA1CA2CYP2A6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111600031-A | Porous carbon coated FeS2Nano flower lithium ion battery cathode material and preparation method thereof | 南陵县巍曙新材料科技有限责任公司 | 2020-08-28 | — | — | CN | claimed |
| EP-4566616-A1 | PARTICLE FOR USE IN AGGLUTINATION METHOD, TEST PARTICLE, REAGENT, TEST KIT, METHOD FOR PRODUCING PARTICLE, AND METHOD FOR DETECTING TARGET SUBSTANCE | CANON KABUSHIKI KAISHA (JP) | 2025-06-11 | — | — | EP | disclosed |
| US-20250180548-A1 | PARTICLE FOR USE IN AGGLUTINATION METHOD, TEST PARTICLE, REAGENT, TEST KIT, METHOD FOR PRODUCING PARTICLE, AND METHOD FOR DETECTING TARGET SUBSTANCE | CANON KABUSHIKI KAISHA (JP) | 2025-06-05 | — | — | US | disclosed |
| US-11548984-B2 | Light- or heat-curing method and curable resin composition | FUJIFILM WAKO PURE CHEMICAL CORPORATION (JP) | 2023-01-10 | — | — | US | disclosed |
| CN-110678500-B | Photo-or thermosetting method and curable resin composition | 富士胶片和光纯药株式会社 | 2022-10-14 | — | — | CN | disclosed |
| CN-108602955-B | Photocuring method, compound used in photocuring method, and composition | 富士胶片和光纯药株式会社 | 2021-08-06 | — | — | CN | disclosed |
| US-10774062-B2 | Photocuring method, compound and composition used therein | FUJIFILM WAKO PURE CHEMICAL CORPORATION (JP) | 2020-09-15 | — | — | US | disclosed |
| CN-111600031-A | Porous carbon coated FeS2Nano flower lithium ion battery cathode material and preparation method thereof | 南陵县巍曙新材料科技有限责任公司 | 2020-08-28 | — | — | CN | disclosed |
| CN-111600031-A | Porous carbon coated FeS2Nano flower lithium ion battery cathode material and preparation method thereof | 南陵县巍曙新材料科技有限责任公司 | 2020-08-28 | — | — | CN | disclosed |
| EP-3409709-B1 | PHOTOCURING METHOD, COMPOUND AND COMPOSITION USED THEREIN | FUJIFILM WAKO PURE CHEMICAL CORP (JP) | 2020-08-19 | — | — | EP | disclosed |
| CN-103447086-B | Loaded palladium catalyst, its preparation method and application | NAT CT NANOSCIENCE NCNST CHINA | 2015-05-06 | — | — | CN | disclosed |
| CN-103447086-A | Loaded palladium catalyst, its preparation method and application | NAT CT NANOSCIENCE NCNST CHINA | 2013-12-18 | — | — | CN | disclosed |
| US-20130119363-A1 | FLUORINE-CONTAINING AROMATIC COMPOUND, ORGANIC SEMICONDUCTOR MATERIAL AND ORGANIC THIN FILM DEVICE | ASAHI GLASS COMPANY, LIMITED (JP) | 2013-05-16 | — | — | US | disclosed |
| US-20130072523-A1 | ANALOGUES FOR THE TREATMENT OR PREVENTION OF FLAVIVIRUS INFECTIONS | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2013-03-21 | — | — | US | disclosed |
| CN-102971283-A | Fluorinated aromatic compound, organic semiconductor material, and organic thin-film device | ASAHI GLASS CO LTD | 2013-03-13 | — | — | CN | disclosed |
| CN-102883718-A | Analogues for the treatment or prevention of flavivirus infections | VERTEX PHARMA | 2013-01-16 | — | — | CN | disclosed |
| EP-2515902-A1 | ANALOGUES FOR THE TREATMENT OR PREVENTION OF FLAVIVIRUS INFECTIONS | Vertex Pharmaceuticals Incorporated (US) | 2012-10-31 | — | — | EP | disclosed |
| WO-2011079327-A1 | ANALOGUES FOR THE TREATMENT OR PREVENTION OF FLAVIVIRUS INFECTIONS | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2011-06-30 | — | — | WO | disclosed |
| US-7914905-B2 | π-conjugated aromatic ring-containing compound and organic electroluminescent device | FUMIE SATO (JP) | 2011-03-29 | — | — | US | disclosed |
| US-20070176164-A1 | -Conjugated aromatic ring-containing compound and organic electroluminescent device | FUMIE SATO (JP) | 2007-08-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130072523-A1 | ANALOGUES FOR THE TREATMENT OR PREVENTION OF FLAVIVIRUS INFECTIONS | C1QBP, IRF3, IFNAR1 | CYP1A1 1102/4885CYP1B1 365/4885HDAC8 2686/4885 |
| US-10774062-B2 | Photocuring method, compound and composition used therein | ESD, TMT1A, PAM | CYP1A1 559/4885CYP1B1 417/4885HDAC8 2176/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.